Jennifer Grebow

What are the biggest problems in the dietary supplements market, and will changing DSHEA fix them?

Why Pharmavite believes mental health and OTC alternatives are two of the biggest opportunities moving forward for health, wellness, and supplements

Last week, California’s Assembly Health Committee voted to ban sales of weight-loss dietary supplements to minors. The bill is headed for another round of votes and could ultimately be signed into law.

Increased stress and tiredness, especially over the past year, are sending consumers to supplement and food shelves to find support.

Can supplement companies do a better job of teaching customers about what to expect from immune-health supplements?

The FDA import alert, issued to two foreign companies over stimulant ingredient higenamine, could have widescale repercussions in the dietary supplements industry by finally getting more firms to file New Dietary Ingredient notifications.

Life Extension’s Michael A. Smith, MD, gives Nutritional Outlook a glimpse of what the future—and present—holds in leveraging AI technology to create healthy-aging products.

The 5-part program will dive deep into cultivation, extraction, processing, testing, third-party certifications, and more.

Skyrocketing output and social distancing were some of the major challenges production equipment helped companies conquer in 2020. What will 2021 look like?

Industry must work to promote consumer access to supplements and fight initiatives to restrict access, especially at the state level, said NPA leaders during an association webcast.

Multivitamins saw skyrocketing sales during the COVID-19 pandemic. Experts discuss expectations for 2021 and how multivitamins will continue to evolve.

The COVID-19 pandemic plus an unclear legal future slowed CBD sales in 2020. Will CBD's prospects improve in 2021?

Vitamin D saw sales and usage grow in 2020, including possibly due to emerging research linking vitamin D supplementation with COVID-19 outcomes. Hear experts discuss why science will keep the spotlight on vitamin D in 2021.

Major retailers like Amazon and CVS now require dietary supplements to pass their own retailer standards, but some in industry signal potential for chaos.

Melatonin saw huge sales gains in 2020 during the COVID-19 pandemic from consumers seeking sleep support. What will the market look like in 2021?

Vitamin C sales grew drastically in 2020 during the COVID-19 pandemic, thanks to the fact that immune health and vitamin C are practically synonymous. But will this growth sustain in 2021? And what will the supply chain look like for vitamin C in 2021?

Predictions from Nutritional Outlook's esteemed Editorial Advisory Board.

Dietary supplement industry associations and leaders share 2021 regulatory predictions.

Experts predict 2021’s hottest food and beverage flavors.

Experts discuss the ongoing challenges and opportunities facing the plant protein market.

The company’s landmark cranberry health claim win will benefit consumers and the industry at large.

The company is carving out its own stake in the PEA market in a big way: with heavy investment in research and development.

In the United States, probiotics remain stuck in a murky regulatory environment, one that stifles innovation and market growth, and, at the end of the day, blocks potential health benefits for the consumer.

Celltrient is a three-product line that addresses three key aspects of cellular health: cellular energy, cellular protection, and cellular strength.

The U.S. dietary supplement industry can and should increase diversity both within industry and in consumer outreach, said panelists at the Council for Responsible Nutrition’s “NOW, NEW, NEXT” conference.

The Council for Responsible Nutrition released detailed results of its latest consumer surveys on U.S. dietary supplement usage in 2020 during its virtual “NOW, NEW, NEXT” conference last week.

Is there a way to strengthen FDA’s regulatory enforcement of dietary supplements? FDA’s Steven Tave discussed the obstacles at CRN’s virtual “NOW, NEW, NEXT” conference on October 14—and industry responded.

The COVID-19 pandemic has upended the dietary supplement supply chain in many ways. One of the biggest bottlenecks, however, is occurring where one might not expect: packaging.

Panelists at Nutritional Outlook’s September 24 webcast described the effects of volatile market demand on dietary supplement supply chains during the COVID-19 pandemic.

Michael McGuffin, president of the American Herbal Products Association, talks about why the time is right for the association’s first Sports Nutrition Congress happening on October 21.